###begin article-title 0
cGMP-Dependent Protein Kinase I Is Crucial for Angiogenesis and Postnatal Vasculogenesis
###end article-title 0
###begin p 1
Conceived and designed the experiments: AA CH SF MEM RF SD. Performed the experiments: AA CH SF RF. Analyzed the data: AA CH SF RF SD. Contributed reagents/materials/analysis tools: SF FH MEM RF. Wrote the paper: AA CH RF SD. Made critical revision of the drafted manuscript for important intellectual content: FH MEM.
###end p 1
###begin p 2
Current address: School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom,
###end p 2
###begin p 3
Current address: Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain
###end p 3
###begin title 4
Background
###end title 4
###begin p 5
Endothelium-derived nitric oxide plays an important role for the bone marrow microenvironment. Since several important effects of nitric oxide are mediated by cGMP-dependent pathways, we investigated the role of the cGMP downstream effector cGMP-dependent protein kinase I (cGKI) on postnatal neovascularization.
###end p 5
###begin title 6
Methodology/Principal Findings
###end title 6
###begin p 7
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
In a disc neovascularization model, cGKI-/- mice showed an impaired neovascularization as compared to their wild-type (WT) littermates. Infusion of WT, but not cGKI-/- bone marrow progenitors rescued the impaired ingrowth of new vessels in cGKI-deficient mice. Bone marrow progenitors from cGKI-/- mice showed reduced proliferation and survival rates. In addition, we used cGKIalpha leucine zipper mutant (LZM) mice as model for cGKI deficiency. LZM mice harbor a mutation in the cGKIalpha leucine zipper that prevents interaction with downstream signaling molecules. Consistently, LZM mice exhibited reduced numbers of vasculogenic progenitors and impaired neovascularization following hindlimb ischemia compared to WT mice.
###end p 7
###begin title 8
Conclusions/Significance
###end title 8
###begin p 9
Our findings demonstrate that the cGMP-cGKI pathway is critical for postnatal neovascularization and establish a new role for cGKI in vasculogenesis, which is mediated by bone marrow-derived progenitors.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 96 99 96 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Murohara1">[1]</xref>
###xml 198 201 198 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Aicher1">[2]</xref>
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Folkman1">[3]</xref>
###xml 456 459 456 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Risau1">[4]</xref>
###xml 460 463 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Shi1">[6]</xref>
###xml 621 624 621 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Aicher1">[2]</xref>
###xml 626 629 626 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Iwakura1">[7]</xref>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Santhanam1">[10]</xref>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Hornig1">[11]</xref>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Gallagher1">[13]</xref>
###xml 951 955 951 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Heeschen1">[14]</xref>
###xml 1215 1219 1215 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Sasaki1">[15]</xref>
###xml 1221 1225 1221 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Segal1">[16]</xref>
###xml 1544 1548 1544 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Vaandrager1">[17]</xref>
###xml 1608 1612 1608 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Feil1">[18]</xref>
###xml 1614 1618 1614 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Hofmann1">[19]</xref>
###xml 1683 1684 1683 1684 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1874 1875 1867 1868 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2085 2088 2078 2081 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 688 696 <span type="species:ncbi:9606">patients</span>
###xml 826 834 <span type="species:ncbi:9606">patients</span>
###xml 1016 1024 <span type="species:ncbi:9606">patients</span>
###xml 2089 2093 <span type="species:ncbi:10090">mice</span>
###xml 2098 2102 <span type="species:ncbi:10090">mice</span>
###xml 2163 2167 <span type="species:ncbi:10090">mice</span>
Mice deficient for endothelial nitric oxide synthase (eNOS) show a defective neovascularization [1], which is, at least in part, related to an impaired mobilization of vasculogenic progenitor cells [2]. In contrast to angiogenesis, which results from the migration and proliferation of pre-existing mature endothelial cells [3], vasculogenesis is based on the recruitment and incorporation of bone marrow-derived progenitors to sites of neovascularization [4]-[6]. Endothelium-derived nitric oxide (NO) plays an essential role in the bone marrow microenvironment and is essential for the mobilization of progenitor cells [2], [7]-[10]. However, NO bioavailability is typically reduced in patients with diabetes, coronary artery disease, and ischemic cardiomyopathy (ICMP) [11]-[13]. Consequently, bone marrow progenitors from patients with diabetes or ICMP show a reduced neovascularization capacity, which is a drawback for their use in cell therapy [14]. The impaired functional activity of bone marrow cells from patients could be partially restored after pharmacological enhancement of eNOS expression or nitric oxide donors, which highlights the important role of endothelium-derived NO for neovascularization [15], [16]. One important downstream signaling pathway of endothelium-derived NO is mediated by cyclic guanosine monophosphate (cGMP) as second messenger. Elevated levels of intracellular cGMP modulate phosphodiesterases, open cation channels, and activate cGMP-dependent protein kinases (cGK; also called protein kinase G; PKG) [17]. The cGKs belong to the family of serine/threonine kinases [18], [19]. Mammals have two cGK genes, which encode cGKI and cGKII. The NH2-terminus of cGKI is encoded by two alternative exons producing the isoforms cGKIalpha and cGKIbeta. The cGKI isoforms are soluble enzymes and interact with several proteins through their NH2-termini containing leucine/isoleucine zippers (LZ). Here, we investigated the role of the NO downstream signaling protein cGKI for postnatal neovascularization in two different models for cGKI deficiency, cGKI-/- mice and mice with a cGKI mutation that affects downstream signaling (LZM mice).
###end p 11
###begin title 12
Results
###end title 12
###begin p 13
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 589 592 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 614 621 614 621 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 614 621 614 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g001"><bold>Fig. 1A</bold></xref>
###xml 723 730 723 730 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1B</bold>
###xml 723 730 723 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g001"><bold>Fig. 1B</bold></xref>
###xml 812 815 812 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 878 885 878 885 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1C</bold>
###xml 878 885 878 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g001"><bold>Fig. 1C</bold></xref>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
To study the role of cGKI for neovascularization in vivo, we subcutaneously implanted discs into the flanks of cGKI-/- mice and their wild-type (WT) littermates. The implantation of discs stimulates neovascularization due to sterile inflammation. After two weeks, animals were sacrificed, and, prior to explantation of the disks, fluorescent microspheres were infused into the circulation to demonstrate the perfusion of the vessels growing from the rim to the center of the disc. Gross examination of the explanted disk already revealed a clear reduction in the vascularized area for cGKI-/- mice compared to WT (Fig. 1A). In addition, formation of neovessels was demonstrated by staining for the endothelial marker CD31 (Fig. 1B). Quantitative analysis demonstrated that neovascularization of the discs in cGKI-/- mice was strongly reduced compared with their WT littermates (Fig. 1C).
###end p 13
###begin title 14
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Growth of vessels in the neovascularization disc model of cGKI-/- and wild-type (WT) mice.
###end title 14
###begin p 15
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
(A) Discs after explantation from cGKI-/- and WT mice. (B) Vessels growing from the rim of the disc into the center in cGKI-/- and WT mice identified by staining with CD31 (green). (C) Quantification of the vascularized area (n = 10).
###end p 15
###begin p 16
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Draijer1">[20]</xref>
###xml 396 399 396 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 559 560 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 571 574 571 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 626 629 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 646 653 646 653 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 646 653 646 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g002"><bold>Fig. 2A</bold></xref>
###xml 777 780 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 805 812 805 812 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 805 812 805 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g002"><bold>Fig. 2A</bold></xref>
###xml 945 948 945 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 977 984 977 984 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 977 984 977 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g002"><bold>Fig. 2B</bold></xref>
###xml 1169 1172 1169 1172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
###xml 1173 1177 <span type="species:ncbi:10090">mice</span>
Disc neovascularization depends on both angiogenesis and vasculogenesis. Therefore, sprouting of pre-existing endothelial cells, which have been reported to express cGKI [20], is likely to be involved in disc neovascularization. To evaluate the role of vasculogenesis, i.e. the involvement of bone marrow-derived progenitor cells, in the impaired neovascularization of sponges implanted into cGKI-/- mice, we examined the capacity of bone marrow-derived progenitors to restore neovascularization in the disc model after their systemic infusion. We injected 106 donor cGKI-/- or WT bone marrow mononuclear cells (BMC) into cGKI-/- recipient mice (Fig. 2A). Intravenous cell therapy with WT but not cGKI-deficient donor BMC clearly rescued the impaired neovascularization of cGKI-/- recipient mice (p<0.01; Fig. 2A). Consistently, neovascularization in WT recipient mice could be strongly enhanced by injection of WT BMC, whereas injection of cGKI-/- BMC had only a weak effect (Fig. 2B). These data imply that cGKI in bone marrow progenitor cells plays an important role to restore postnatal neovascularization in an inflammation-induced neovascularization model in cGKI-/- mice.
###end p 16
###begin title 17
Disc neovascularization following cell therapy.
###end title 17
###begin p 18
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 100 103 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 181 184 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
(A) Vascularized area after intravenous injection of cGKI-/- or WT bone marrow cells (BMC) into cGKI-/- recipients (n>/=7). (B) Vascularized area after intravenous injection of cGKI-/- or WT bone marrow cells (BMC) into WT recipients (n>/=6).
###end p 18
###begin p 19
###xml 266 267 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 384 393 384 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A+B</bold>
###xml 384 393 384 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g003"><bold>Fig. 3A+B</bold></xref>
###xml 726 727 726 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 732 733 732 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 764 773 764 773 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A&#8211;C</bold>
###xml 764 773 764 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g004"><bold>Fig. 4A&#8211;C</bold></xref>
###xml 902 903 902 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 908 909 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 948 951 948 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 958 967 958 967 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A+B</bold>
###xml 958 967 958 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g004"><bold>Fig. 4A+B</bold></xref>
###xml 1013 1014 1013 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1019 1020 1019 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1071 1074 1071 1074 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1114 1121 1114 1121 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4C</bold>
###xml 1114 1121 1114 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g004"><bold>Fig. 4C</bold></xref>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
###xml 1075 1079 <span type="species:ncbi:10090">mice</span>
To provide further insights into the regulation of vasculogenesis through cGMP-dependent pathways, we examined the role of cGKI on the functional capacity of bone marrow-derived progenitor cells. First, we demonstrated that cGKI is expressed in freshly isolated CD45+ hematopoietic bone marrow cells, freshly isolated total bone marrow, as well as cultured bone marrow stromal cells (Fig. 3A+B). The most prominent expression of cGKI was found in cultured bone marrow stromal cells, most likely due the relative enrichment of endothelial cells and fibroblasts in cultured bone marrow stromal cells. To assess the functional capacity of bone marrow-derived progenitor cells, we measured proliferation and apoptosis rates in Lin-sca-1+ bone marrow progenitor cells (Fig. 4A-C). BrdU incorporation as a marker of cell proliferation was assessed by flow cytometry and demonstrated a strong reduction in Lin-sca-1+ bone marrow progenitor cells from cGKI-/- mice (Fig. 4A+B). Simultaneously, the number of apoptotic Lin-sca-1+ bone marrow progenitor cells was increased in cGKI-/- mice as assessed by annexin V binding (Fig. 4C). These results suggest that cGKI promotes proliferation and survival of bone marrow-derived progenitor cells, which contributes to neovascularization.
###end p 19
###begin title 20
Expression of cGKI in the bone marrow.
###end title 20
###begin p 21
###xml 138 139 138 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 395 396 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
(A) Representative western blot of cultured bone marrow stromal cells, freshly isolated total bone marrow cells, and freshly isolated CD45+ bone marrow leukocytes using an antibody against cGKI (cGKIcom: detecting cGKIalpha and cGKIbeta). ERK1/2 was used as loading control. (B) Quantification of the ratio cGKIcom : ERK1 protein expression in cultured stromal cells, total bone marrow, and CD45+ bone marrow in 129/Sv WT mice (n = 3 / group, p = n.s.).
###end p 21
###begin title 22
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Functional capacity of BMC from cGKI-/- and WT mice.
###end title 22
###begin p 23
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 142 143 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 339 342 339 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
(A) Representative FACS analysis of Lin- BMC after pulsing with BrdU for 1 h and staining with BrdU-FITC and sca-1-PE. (B) Proliferation (BrdU+) of sca-1+Lin- bone marrow progenitor cells from cGKI-/- and WT mice (gated on lymphocyte-monocyte fraction; n = 4). (C) Apoptosis (annexinV+) of sca-1+Lin- bone marrow progenitor cells from cGKI-/- and WT mice (gated on lymphocyte-monocyte fraction; n = 3).
###end p 23
###begin p 24
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Feil1">[18]</xref>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Hofmann1">[19]</xref>
###xml 286 289 286 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Michael1">[21]</xref>
###xml 445 446 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 726 729 718 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 887 894 879 886 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5A</bold>
###xml 887 894 879 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g005"><bold>Fig. 5A</bold></xref>
###xml 955 956 947 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 992 999 984 991 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5B</bold>
###xml 992 999 984 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g005"><bold>Fig. 5B</bold></xref>
###xml 1133 1142 1125 1134 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A+B</bold>
###xml 1133 1142 1125 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004879-g006"><bold>Fig. 6A+B</bold></xref>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 986 990 <span type="species:ncbi:10090">mice</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
###xml 1273 1277 <span type="species:ncbi:10090">mice</span>
The cGKI-/- mice used for the above experiments show multiple phenotypes and a reduced life expectancy, which complicates long-term experiments with adult mice and excludes assessment of neovascularization in ischemia models [18], [19]. To validate the results obtained in juvenile cGKI-/- mice in an adult model of cGKI deficiency, we also examined the neovascularization capacity of so-called LZM mice [21]. LZM mice carry a mutation in the NH2-terminal protein interaction domain of cGKIalpha that results in disruption of cGKIalpha interactions with key downstream signaling molecules like myosin phosphatase and Rho kinase, but does not reduce the life span of the mutant mice. In line with the results from juvenile cGKI-/- mice, we observed in LZM mice a reduced neovascularization capacity, measured as relative Laser Doppler-derived blood flow, in a model of hindlimb ischemia (Fig. 5A). In addition, the vessel density assessed as number of CD31+ capillaries was lower in LZM mice (Fig. 5B). Consistently, the number of spleen-derived vasculogenic progenitor cells and vasculogenic colonies was also decreased in LZM mice (Fig. 6A+B). The reduced number and colony formation of vasculogenic progenitors might be involved in the impaired neovascularization of LZM mice. These results suggest that cGKIalpha in vasculogenic progenitors is also involved in the neovascularization response following ischemia.
###end p 24
###begin title 25
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Neovascularization capacity in an unilateral hindlimb ischemia model using LZM and WT mice.
###end title 25
###begin p 26
###xml 98 99 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 116 117 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
(A) Perfusion is measured as relative Laser Doppler-derived blood flow (n>/=5). (B) Number of CD31+ capillaries / mm2 in ischemic hindlimbs of LZM versus WT littermates mice (n = 12-18 sections from 4-6 mice / group).
###end p 26
###begin title 27
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Number of spleen-derived early vasculogenic progenitor cells (A) and vasculogenic colonies (B) in LZM and WT mice (n>/=9).
###end title 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Pfeifer1">[22]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Foller1">[25]</xref>
###xml 786 787 786 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1128 1132 1120 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Michael1">[21]</xref>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1152 1156 <span type="species:ncbi:10090">mice</span>
###xml 1286 1290 <span type="species:ncbi:10090">mice</span>
The major finding of our investigation is a novel role for cGKI in the functionality of bone marrow-derived progenitors. Signaling through cGKI significantly contributed to postnatal neovascularization via stimulation of vasculogenic processes both in the setting of inflammation and following tissue ischemia. Our data implicate that the cGMP-cGKI pathway plays a pivotal stimulatory role for neovascularization, which is at least in part mediated through bone marrow progenitors. cGKI-/- mice exhibit a markedly reduced life span with defects in the relaxation of vascular and visceral smooth muscle cells, disturbed platelets and red blood cells, which limits the availability of adult mice [22]-[25]. Therefore, we further validated our findings using mice with a mutation in the NH2-terminal protein interaction domain of cGKIalpha, the so-called leucine zipper mutant (LZM) mice. This mutation selectively inhibits downstream signaling of the cGKIalpha isoform while leaving the enzyme intact. LZM mice exhibit a vascular phenotype with increased blood pressure, but reach adulthood without limitations in their life span [21]. Consistently, LZM mice exhibited reduced numbers of vasculogenic progenitors and impaired neovascularization following hindlimb ischemia compared to WT mice.
###end p 29
###begin p 30
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Zhang1">[26]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Pyriochou1">[27]</xref>
###xml 543 547 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Senthilkumar1">[28]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Yamahara1">[29]</xref>
###xml 1194 1197 1194 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1411 1418 1411 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1563 1567 1563 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Oshita1">[30]</xref>
###xml 1696 1700 1696 1700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Foller1">[25]</xref>
###xml 1702 1706 1702 1706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Chan1">[31]</xref>
###xml 1707 1711 1707 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Fiedler1">[34]</xref>
###xml 290 293 <span type="species:ncbi:10116">rat</span>
###xml 458 463 <span type="species:ncbi:10090">mouse</span>
###xml 1198 1202 <span type="species:ncbi:10090">mice</span>
Several previous studies have analyzed the importance of cGMP signaling for neovascularization, particularly for angiogenesis, i.e. the generation of new vessels through local expansion of mature endothelial cells. For instance, systemic cGMP enhancement augmented angiogenesis in ischemic rat brains [26]. Recently, sildenafil, a phosphodiesterase-5 inhibitor, which inhibits cGMP degradation, has been reported to enhance angiogenesis [27]. Moreover, in a mouse model of hindlimb ischemia, sildenafil promoted recovery of vascular perfusion [28]. Based on the use of pharmacological tools it appeared that neovessel growth in this experimental set up was stimulated by a cGMP-cGK pathway that was independent of nitric oxide production. In line with these previous and our present experiments, a study by Yamahara et al. demonstrated the significance of the the natriuretic peptide-cGMP-cGKI pathway for angiogenesis [29]. However, the involvement of cGMP-cGKI signaling in vasculogenesis, i.e. the contribution of bone marrow-derived progenitor cells to postnatal neovascularization, had not been investigated to date. Our results provide evidence that the reduced neovascularization in cGKI-/- mice is at least in part related to an impaired functional activity of bone marrow-derived progenitors as evidenced by their diminished proliferation and survival, translating into reduced disc neovascularization in vivo. The first description that cGMP stimulation could trigger proliferation of hematopoietic stem cells was provided by Oshita et al. back in 1977 [30]. It is now becoming apparent that the cGMP-cGKI signaling pathway has anti-apoptotic/pro-survival effects in diverse cell types [25], [31]-[34].
###end p 30
###begin p 31
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Feil1">[18]</xref>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 448 455 448 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Hofmann1">[19]</xref>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
About 50% of the cGKI-/- mice die before the age of 5 to 6 weeks [18] representing an important drawback of this model. Therefore, we further corroborated our experimental findings derived from cGKI-/- mice using LZM mice. The apparent spontaneous phenotype of LZM mice is hypertension and vascular contractile dysfunction in both large and resistance arteries, but otherwise these mice appear to develop and age normally. More than ten downstream in vivo target substrates for cGKI have been found to date [19]. Currently, however, we have not yet identified the downstream target molecules, which might be affected by the disturbed leucine zipper interactions in bone marrow-derived progenitors.
###end p 31
###begin p 32
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Surks1">[35]</xref>
###xml 316 320 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Michael1">[21]</xref>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 543 548 <span type="species:ncbi:10090">mouse</span>
In vascular smooth muscle cells, cGKI binds to myosin light chain phosphatase (MLCP), which mediates relaxation through a leucine zipper domain-mediated interaction [35]. LZM knockin mice harbor a mutation that disrupts the leucine zipper domain required for cGKIalpha-mediated regulation of MLCP-induced relaxation [21]. Of note, the level of the mutant cGKIalpha protein in the vascular wall is comparable to the cGKIalpha protein level found in WT mice, and mutant cGKIalpha protein remains responsive to cGMP. Thus, key feature of the LZM mouse model is disruption of interactions between cGKIalpha and its targets, despite preserved kinase activity.
###end p 32
###begin p 33
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 411 415 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Diller1">[36]</xref>
###xml 365 373 <span type="species:ncbi:9606">patients</span>
Collectively, our data highlight the in vivo importance of the cGMP-cGKI pathway for postnatal neovascularization and particularly emphasize the role of the cGKIalpha isoform in vasculogenesis. Interestingly, a very recent study demonstrated the potential of the cGMP-elevating drug sildenafil to increase the number of circulating vasculogenic progenitor cells in patients with pulmonary arterial hypertension [36]. Further studies using pharmacological cGMP elevation for the pre-treatment of bone marrow-derived progenitors will give more insights into the therapeutic use of modulating the cGMP-cGKI pathway for cardiovascular cell therapy approaches.
###end p 33
###begin title 34
Materials and Methods
###end title 34
###begin title 35
Animals
###end title 35
###begin p 36
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Wegener1">[37]</xref>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 370 371 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 537 541 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Michael1">[21]</xref>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">Mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
The generation of a cGKI null allele (also termed L- allele) by Cre-mediated excision of the loxP-flanked exon 10 of the cGKI gene in germ cells has been described previously [37]. Juvenile (3-5 weeks old) male and female cGKI-/- mice on a 129/Sv genetic background and their wild-type (WT) littermates were used for experiments. Mice with a selective mutation in the NH2-terminal protein interaction domain of cGKIalpha (LZM mice) have been used at adult age (males, C57BL/6 genetic background, crossed >10 generations, 8-10 weeks old) [21]. LZM mice harbor a discrete mutation in cGKIalpha that disrupts the leucine zipper (LZ) domain that mediates the interaction of cGKIalpha with downstream target proteins. In LZM mice the initial four leucine/isoleucine codons in exon1a of the endogenous cGKIalpha gene were replaced by alanines.
###end p 36
###begin p 37
###xml 29 33 <span type="species:ncbi:10090">mice</span>
For all invasive procedures, mice were anesthetized with ketamine (100 mg/kg). For induction of hindlimb ischemia, anaesthesia was performed using medetomidine (Domitortrade mark; Pfizer, Karlsruhe, Germany; 0.1 mg/kg). For post-operative analgesia carprofen (Rimadyltrade mark; Pfizer; 5 mg/kg) was administered. All animal protocols were approved by the Institutional Animal Care and Use Committee (Regierungsprasidium Darmstadt, Germany).
###end p 37
###begin title 38
BrdU proliferation assay
###end title 38
###begin p 39
###xml 120 121 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 175 179 <span type="species:ncbi:9913">calf</span>
Total bone marrow cells were obtained by flushing femur and tibia bones with PBS using 27-gauge needles. Then, cells (106 / ml) were resuspended in RPMI 1640 medium+10% fetal calf serum (both from Invitrogen, Karlsruhe, Germany), and pulsed with 10 microM BrdU (BrdU flow kit, BD biosciences (BD), Heidelberg, Germany) for one hour. Staining of surface antigens with a cocktail of biotinylated antibodies against lineage markers (lineage marker panel: anti-CD3, anti-B220, anti-CD11b, anti-Gr, anti-TER119) was performed for 20 min on ice. This step was followed by streptavidin-APC (BD) together with sca-1-PE (BD) staining for another 20 min on ice. Cells were fixed and permeabilized with Cytofix / Cytoperm buffer according to the manufacturer's instructions (BrdU flow kit) and treated with DNase prior to intracellular staining with FITC-labeled BrdU for 20 min at room temperature. Stained cells were then analyzed by flow cytometry using a FACS Calibur (BD) using CellQuest software. Specific cell fluorescence intensity was calculated by subtracting the signal obtained with isotype-matched control antibodies (BD).
###end p 39
###begin title 40
Apoptosis assay
###end title 40
###begin p 41
###xml 78 84 <span type="species:ncbi:10090">murine</span>
Total bone marrow cells were cultured for 24 h in ex-vivo 10 medium+100 ng/ml murine SCF (Peprotech, Rocky Hill, NJ). Then, bone marrow cells were stained with the biotinylated lineage marker panel (BD) for 20 min on ice, followed by streptavidin-PE (BD) together with sca-1-FITC and annexinV-APC (both BD) for another 20 min at room temperature using annexin binding buffer (BD). Cells were then immediately analyzed by flow cytometry using a FACS Calibur.
###end p 41
###begin title 42
Vasculogenic progenitor assay
###end title 42
###begin p 43
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 766 770 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Walter1">[38]</xref>
Spleens were aseptically removed, homogenized, and laid over Ficoll solution (Biocoll, Biochrom AG, Berlin, Germany). Mononuclear cells were obtained from the Ficoll's interphases and washed with PBS. Then, 4x106 cells per well were seeded on fibronectin-precoated 24-well plates (10 microg/ml fibronectin in PBS for 1 h at room temperature; Sigma-Aldrich, Taufkirchen, Germany) and cultured in 500 microl EBM medium+20% FCS+supplements (Cambrex Bio Science, Verviers, Belgium) at 37degreesC. After four days of culture, vasculogenic progenitors were assayed by co-staining with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine-labeled acetylated low-density lipoprotein (DiLDL; CellSystems, St. Katharinen, Germany) and FITC-conjugated lectin (Sigma-Aldrich) [38].
###end p 43
###begin p 44
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Ingram1">[39]</xref>
To obtain colonies with vasculogenic activity, we used a modified version of the protocol of Ingram et al. [39] using fibronectin and supplemented EBM medium scoring clusters of cells after 7 days.
###end p 44
###begin title 45
Western blot analysis
###end title 45
###begin p 46
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 786 790 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Feil3">[40]</xref>
###xml 411 415 <span type="species:ncbi:9913">calf</span>
###xml 761 767 <span type="species:ncbi:9986">rabbit</span>
Total bone marrow cells, CD45+ bone marrow leukocytes, and cultured bone marrow stromal cells were used for Western blot analysis. CD45+ cells were isolated by immunomagnetic selection using magnetically labeled anti-CD45 microbeads and magnetic cell sorting (Miltenyi Biotec, Bergisch Gladbach, Germany). To obtain bone marrow stromal cells, total bone marrow cells were cultured in RPMI 1640 medium+10% fetal calf serum (both from Invitrogen) for one week. Cells were fed with fresh medium every other day and non-adherent cells were discarded. After trypsinization of the adherent stromal cells, the pelleted cells were resuspended in lyzing buffer. Finally, proteins were separated on a SDS gel, transferred to a PVDF membrane and stained with a polyclonal rabbit antiserum to cGKI [40]. ERK1/2 (p44/p42 MAPK) antibodies were used as a loading control (Cell Signaling Technology, Danvers, MA).
###end p 46
###begin title 47
Disc neovascularization model
###end title 47
###begin p 48
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Fajardo1">[41]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Heeschen2">[42]</xref>
###xml 320 323 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 420 423 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 712 713 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 734 737 734 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 975 979 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004879-Springer1">[43]</xref>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
A disc of polyvinyl alcohol sponge (Rippey Corp., El Dorado Hills, California), covered with nitrocellulose cell-impermeable filters (Millipore Corp., Burlington, Massachusetts), allows vessels to grow only through the rim of the disc [41], [42]. The discs were subcutaneously implanted in the back of 3-5 weeks old cGKI-/- mice or their WT littermates. For cell therapy, bone marrow cells were harvested from donor cGKI-/- or WT mice by aseptically flushing femurs and tibias with PBS. Bone marrow mononuclear cells (BMC) were isolated by density-gradient centrifugation with Biocoll separating solution (density 1.077; Biochrom AG). Twenty-four hours after implantation of sponges, we intravenously injected 106 BMC from either cGKI-/- or WT BMC . Two weeks later, space-filling fluorescent microspheres (0.2 microm; Molecular Probes Inc., Eugene, OR) were systemically injected into the left ventricle to identify functionally connected microvessels in the implaned disks [43]. The area of the disc invested by fibrovascular ingrowth was assessed using a Axiovert 40 fluorescence microscope (Zeiss, Oberkochen, Germany). Alternatively, outgrowth of vessels was examined by CD31 staining (CD31-FITC; BD biosciences, Heidelberg, Germany) for endothelial cells.
###end p 48
###begin title 49
Hind limb ischemia model
###end title 49
###begin p 50
To induce unilateral hind limb ischemia, the proximal portion of the right femoral artery including the superficial and the deep branch were occluded using an electrical coagulator. The overlying skin was closed using surgical staples. Limb perfusion was assessed with a laser Doppler blood flow imager (Laser Doppler Perfusion Imager System, moorLDItrade mark-Mark 2, Moor Instruments, Wilmington, Delaware) after one week. Before initiating scanning, animals were placed on a heating pad at 37degreesC to minimize variations in temperature. Calculated perfusion is expressed as the ratio of ischemic to non-ischemic hind limb perfusion.
###end p 50
###begin title 51
Histology
###end title 51
###begin p 52
Capillaries were scored in 8 microm frozen sections of the adductor muscles by staining for CD31 (PE-labeled; BD Biosciences). Images were obtained by confocal microscopy (LSM 510 Meta, Zeiss, Germany).
###end p 52
###begin title 53
Statistical analysis
###end title 53
###begin p 54
Results are expressed as mean+/-SEM. Overall comparison of the treatment groups was performed with the Kruskal-Wallis test followed by post-hoc pairwise comparison using the Mann-Whitney test. P values<0.05 were considered statistically significant. Analyses were performed with SPSS 15.0 (SPSS Inc.).
###end p 54
###begin p 55
We are indebted to Christiane Mildner-Rihm, Tino Roxe, Ariane Fischer, Marion Muhly-Reinholz, Barbara Birk, and Jaimy Saif for their excellent assistance.
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
###end article-title 57
###begin article-title 58
Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells.
###end article-title 58
###begin article-title 59
Angiogenesis in cancer, vascular, rheumatoid and other disease.
###end article-title 59
###begin article-title 60
Mechanisms of angiogenesis.
###end article-title 60
###begin article-title 61
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.
###end article-title 61
###begin article-title 62
Evidence for circulating bone marrow-derived endothelial cells.
###end article-title 62
###begin article-title 63
Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury.
###end article-title 63
###begin article-title 64
Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis.
###end article-title 64
###begin article-title 65
Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
###end article-title 65
###begin article-title 66
Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells.
###end article-title 66
###begin article-title 67
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure.
###end article-title 67
###begin article-title 68
Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.
###end article-title 68
###begin article-title 69
Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.
###end article-title 69
###begin article-title 70
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
###end article-title 70
###begin article-title 71
Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.
###end article-title 71
###begin article-title 72
Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes.
###end article-title 72
###begin article-title 73
Signalling by cGMP-dependent protein kinases.
###end article-title 73
###begin article-title 74
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice.
###end article-title 74
###begin article-title 75
Function of cGMP-dependent protein kinases as revealed by gene deletion.
###end article-title 75
###begin article-title 76
###xml 126 131 <span type="species:ncbi:9606">human</span>
Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin.
###end article-title 76
###begin article-title 77
High blood pressure arising from a defect in vascular function.
###end article-title 77
###begin article-title 78
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Defective smooth muscle regulation in cGMP kinase I-deficient mice.
###end article-title 78
###begin article-title 79
Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I.
###end article-title 79
###begin article-title 80
A Stimulatory Role for cGMP-Dependent Protein Kinase in Platelet Activation.
###end article-title 80
###begin article-title 81
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Anemia and splenomegaly in cGKI-deficient mice.
###end article-title 81
###begin article-title 82
###xml 120 123 <span type="species:ncbi:10116">Rat</span>
Nitric Oxide Enhances Angiogenesis via the Synthesis of Vascular Endothelial Growth Factor and cGMP After Stroke in the Rat.
###end article-title 82
###begin article-title 83
The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway.
###end article-title 83
###begin article-title 84
Sildenafil promotes ischemia-induced angiogenesis through a PKG-dependent pathway.
###end article-title 84
###begin article-title 85
Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration.
###end article-title 85
###begin article-title 86
cGMP stimulation of stem cell proliferation.
###end article-title 86
###begin article-title 87
Guanylyl cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) inhibitor KT5823 trigger apoptotic DNA fragmentation in immortalized uterine epithelial cells: anti-apoptotic effects of basal cGMP/PKG.
###end article-title 87
###begin article-title 88
A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells.
###end article-title 88
###begin article-title 89
A heretical view on the role of NO and cGMP in vascular proliferative diseases.
###end article-title 89
###begin article-title 90
cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apoptosis signaling in cardiac myocytes.
###end article-title 90
###begin article-title 91
Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha.
###end article-title 91
###begin article-title 92
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.
###end article-title 92
###begin article-title 93
###xml 86 92 <span type="species:ncbi:10090">murine</span>
cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium.
###end article-title 93
###begin article-title 94
Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
###end article-title 94
###begin article-title 95
###xml 74 79 <span type="species:ncbi:9606">human</span>
Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.
###end article-title 95
###begin article-title 96
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Distribution of cGMP-dependent protein kinase type I and its isoforms in the mouse brain and retina.
###end article-title 96
###begin article-title 97
The disc angiogenesis system.
###end article-title 97
###begin article-title 98
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis.
###end article-title 98
###begin article-title 99
Angiogenesis monitored by perfusion with a space-filling microbead suspension.
###end article-title 99
###begin p 100
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 100
###begin p 101
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by SFB 553 B6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 101

